Press release
I.P.F LAUNCHES A NEW MULTILINGUAL WEBSITE
The International Press Federation (I.P.F.)'s new website is a one-stop-shop for all media professional from all around the globe. The new website, which offers quick and easy access to essential information on I.P.F. and the international media community, is part of the organization’s ongoing efforts to enhance the quality and availability of information to members and news professionals worldwide.
According to James P. Steadland, president of I.P.F. the aim is “to live up to the expectations of the growing number of our members and other freelance journalists spread around the world, who are using press pass”. The website boasts a modern, colorful design with the following main features:
• general information about press card subject
• background information about international press federation
•code of ethics for members
• detailed information in English, French and Spanish
• detailed explanation on how to register
• live chat support
We invite you to visit www.ipf-fip.org today!
IPF, the International Press Federation is an independent and non-partisan media association with its registered office in New York, USA. It promotes and encourages high standard among media professionals through professional development, networking among wide and varied range of journalists, including but not limited to editors, press photographers, print journalists, press spokespeople, cameramen/women, directors, authors, publishers, bloggers, arts critics, anchormen, from print, TV, radio and web media, either full- time, part-time or freelancers thus covering and representing all the interests of media without exclusion.
International Press Federation I.P.F.
Media Contact:
Hannah McPherson
Email: contact@ipf-fip.org
Tel : + 1 845 570 42 65
Fax: + 1 845 503 23 79
Corporate address: 616 Corporate Way, Suite 2-5258, Valley Cottage, New York 10989, USA
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release I.P.F LAUNCHES A NEW MULTILINGUAL WEBSITE here
News-ID: 241387 • Views: …
More Releases for IPF
Idiopathic pulmonary fibrosis (IPF): Market Outlook and Competitive Landscape Re …
LAPS Triple Agonist (HM15211) of Hanmi Pharmaceutical has granted Orphan drug designation for treating Idiopathic pulmonary fibrosis (IPF). Pulmonary fibrosis occurs in the interstitium, which is the lung tissue that provides the scaffolding for the alveoli. Fibrosis thickens the interstitium, making the alveoli stiff so that they are unable to fully expand and hold as much air as they normally should. This thickening also limits the passage of oxygen through…
Idiopathic Pulmonary Fibrosis (IPF) Therapeutics Pipeline Analysis, 2017
The study analyzed that the IPF pipeline comprised of 104 drug candidates, of which 19 drugs are in the Phase II stage of development. The lack of complete cure for IPF fuels the extensive research and development for the IPF therapeutic. There are various drugs that are being developed as novel and promising therapeutics for the treatment of IPF.
Explore Full Report Description At@ https://www.psmarketresearch.com/market-analysis/idiopathic-pulmonary-fibrosis-therapeutics-market
As per the findings of research, it…
Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market US$ 3.5 Billion by 2 …
The global idiopathic pulmonary fibrosis treatment market expected to reach US$ 3.5 billion by 2021, growing at CAGR 14.4% over the forecast period 2017-2021, owing to increasing drug prices and rapid approval of new treatments.
Visit Idiopathic Pulmonary Fibrosis (IPF) Treatment Market by Treatment Type - Pharmacological Treatment (Pirfenidone (Esbriet), Nintedanib (Ofev), Generic Pirfenidone); Non-pharmacological Treatment (Oxygen Therapy, Pulmonary Rehabilitation, Mechanical Ventilation, Lung Transplantation, Other Non-Pharmacological Treatment); Patients by Disease Severity…
Recent Release: Global Idiopathic pulmonary fibrosis (IPF) Market To 2023
MarketResearchReports.Biz presents this most up-to-date research on "Idiopathic pulmonary fibrosis (IPF)- Epidemiology Forecast To 2023"
Idiopathic pulmonary fibrosis (IPF) - Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Idiopathic pulmonary fibrosis (IPF) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Idiopathic pulmonary fibrosis (IPF) prevalent or incident cases segmented by age, sex and…
Idiopathic Pulmonary Fibrosis (IPF) Pipeline, A Novel Advancement for the Treatm …
The study analyzed that the IPF pipeline comprised of 97 therapeutic candidates, of which 15 are in Phase II stage of development. The lack of complete cure for IPF fuels the extensive research and development for the IPF therapeutic. Various drugs are being developed as novel and promising therapeutics for the treatment of IPF.
Browse the Report Summary at: www.psmarketresearch.com/market-analysis/idiopathic-pulmonary-fibrosis-therapeutics-market
Insights on pipeline segments
As per the findings of research, it was found…
Idiopathic Pulmonary Fibrosis (IPF) - Market Insights, Epidemiology and Market F …
DelveInsight is a leading Business Consultant and Market Research Firm which has become the knowledge partner for biotechnology and pharmaceutical companies by providing competitive intelligence information which aids them to strategize and discover the target areas & potential customers for their products.
DelveInsight expertise has expanded from an initial focus on Pipeline & Marketed Reports to Market Forecasting and Epidemiology Reports. Idiopathic Pulmonary Fibrosis (IPF) - Market Insights, Epidemiology…
